Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT02670720
Eligibility Criteria:
Inclusion Criteria:
* Males and non-pregnant, non-lactating females age ≥ 18 years.
* Provide written, informed consent.
* Prior completion of an avoralstat therapeutic study OR a confirmed diagnosis of HAE Type 1 or HAE Type 2.
* Access to appropriate medication for the treatment of acute HAE attacks.
* Adequate contraception.
Exclusion Criteria:
* Females who are pregnant or breast feeding.
* Clinically significant medical condition or medical history.
* Abnormal screening ECG, laboratory or urinalysis finding that is clinically significant.
* Investigational drug exposure within 30 days (except avoralstat).
* History of or current alcohol or drug abuse.
* HIV or active HBV or HCV infection.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02670720
Study Brief:
Protocol Section:
NCT02670720